Homogeneous PLGA-lipid nanoparticle as a promising oral vaccine delivery system for ovalbumin

Asian Journal of Pharmaceutical Sciences

Volumn 9, Issue 3, 2014, Pages 129-136

  Ma, Tongtong ^a,b   Wang, Lianyan ^b   Yang, Tingyuan ^b   Ma, Guanghui ^b   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF PROCESS ENGINEERING   (China)

Author keywords

M cell affinity; Oral delivery; Polymeric lipid nanoparticle; Vaccine

Indexed keywords

BUFFER; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOSOME; NANOPARTICLE; OVALBUMIN; POLYGLACTIN; TETRAMETHYLBENZIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELL ASSAY; COCULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; FEMALE; FRICTION; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; HYPOBARISM; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MOUSE; NANOENCAPSULATION; NONHUMAN; OPTICAL DENSITY; PARTICLE SIZE; PH; POLYMERIZATION; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY; SHEAR STRESS; SURFACE PROPERTY;

EID: 84961368349     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2014.03.002     Document Type: Article

References (24)

1. Mortellaro A., Ricciardi-Castagnoli P. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease. Immunol Cell Biol 2011, 89(3):332-339.
2. Hutchinson E. Vaccination: oral vaccine induces genitorectal immunity. Nat Rev Drug Discov 2012, 11(9). 673-673.
3. Kim S.H., Lee K.Y., Jang Y.S. Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination. Immune Netw 2012, 12(5):165-175.
4. Sarti F., Perera G., Hintzen F., et al. Invivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A. Biomaterials 2011, 32(16):4052-4057.
5. van der Lubben I.M., Verhoef J.C., van Aelst A.C., et al. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary invivo uptake studies in murine Peyer's patches. Biomaterials 2001, 22(7):687-694.
6. Bowersock T.L., HogenEsch H., Suckow M., et al. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 1999, 17(13-14):1804-1811.
7. des Rieux A., Fievez V., Garinot M., et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 2006, 116(1):1-27.
8. Levine M.M. Immunization against bacterial diseases of the intestine. J Pediatr Gastroenterol Nutr 2000, 31(4):336-355.
9. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6(2):148-158.
10. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(4 Suppl.):S45-S53.
11. Kunkel E.J., Butcher E.C. Plasma-cell homing. Nat Rev Immunol 2003, 3(10):822-829.
12. Peek L.J., Middaugh C.R., Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 2008, 60(8):915-928.
13. Madara J.L. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 1998, 60:143-159.
14. Hussain N., Jaitley V., Florence A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 2001, 50(1-2):107-142.
15. Neutra M.R., Mantis N.J., Kraehenbuhl J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001, 2(11):1004-1009.
16. Gullberg E., Leonard M., Karlsson J., et al. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun 2000, 279(3):808-813.
17. Shimosato T., Tomida K., Otani H. Effect of Lactobacillus pentosus ONRIC b0240 on intestinal IgA production in mice fed differing levels of protein. J Agric Food Chem 2011, 59(6):2646-2651.
18. Dimitrov I., Trzebicka B., Müller A.H.E., et al. Thermosensitive water-soluble copolymers with doubly responsive reversibly interacting entities. Prog Polym Sci 2007, 32(11):1275-1343.
19. Patel B., Gupta V., Ahsan F. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. J Control Release 2012, 162(2):310-320.
20. Rafati A., Boussahel A., Shakesheff K.M., et al. Chemical and spatial analysis of protein loaded PLGA microspheres for drug delivery applications. J Control Release 2012, 162(2):321-329.
21. Ho M.L., Fu Y.C., Wang G.J., et al. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J Control Release 2008, 128(2):142-148.
22. Leo E., Ruozi B., Tosi G., et al. PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated. Int J Pharm 2006, 323(1-2):131-138.
23. Ye M., Kim S., Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release 2010, 146(2):241-260.
24. Yoo M.-K., Kang S.-K., Choi J.-H., et al. Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique. Biomaterials 2010, 31(30):7738-7747.